nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—coronary artery disease	0.216	0.678	CbGaD
Pomalidomide—PTGS2—coronary artery disease	0.103	0.322	CbGaD
Pomalidomide—PTGS2—Acetylsalicylic acid—coronary artery disease	0.033	0.0794	CbGbCtD
Pomalidomide—ABCB1—Ticagrelor—coronary artery disease	0.028	0.0675	CbGbCtD
Pomalidomide—CYP1A2—Gemfibrozil—coronary artery disease	0.0228	0.055	CbGbCtD
Pomalidomide—CYP1A2—Clopidogrel—coronary artery disease	0.0198	0.0477	CbGbCtD
Pomalidomide—ABCB1—Clopidogrel—coronary artery disease	0.0173	0.0417	CbGbCtD
Pomalidomide—ABCB1—Perindopril—coronary artery disease	0.0173	0.0417	CbGbCtD
Pomalidomide—CYP3A4—Ticagrelor—coronary artery disease	0.0168	0.0405	CbGbCtD
Pomalidomide—ABCB1—Telmisartan—coronary artery disease	0.0151	0.0365	CbGbCtD
Pomalidomide—ABCB1—Pitavastatin—coronary artery disease	0.0151	0.0365	CbGbCtD
Pomalidomide—CYP3A4—Fenofibrate—coronary artery disease	0.015	0.0361	CbGbCtD
Pomalidomide—ABCB1—Enalapril—coronary artery disease	0.0143	0.0346	CbGbCtD
Pomalidomide—ABCB1—Lisinopril—coronary artery disease	0.0143	0.0346	CbGbCtD
Pomalidomide—ABCB1—Timolol—coronary artery disease	0.0122	0.0294	CbGbCtD
Pomalidomide—CYP3A4—Gemfibrozil—coronary artery disease	0.012	0.0288	CbGbCtD
Pomalidomide—ABCB1—Ezetimibe—coronary artery disease	0.0112	0.0269	CbGbCtD
Pomalidomide—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0109	0.0262	CbGbCtD
Pomalidomide—ABCB1—Captopril—coronary artery disease	0.0107	0.0259	CbGbCtD
Pomalidomide—CYP3A4—Clopidogrel—coronary artery disease	0.0104	0.025	CbGbCtD
Pomalidomide—ABCB1—Simvastatin—coronary artery disease	0.0104	0.025	CbGbCtD
Pomalidomide—ABCB1—Pravastatin—coronary artery disease	0.0101	0.0245	CbGbCtD
Pomalidomide—ABCB1—Lovastatin—coronary artery disease	0.0101	0.0245	CbGbCtD
Pomalidomide—CYP1A2—Losartan—coronary artery disease	0.00967	0.0233	CbGbCtD
Pomalidomide—CYP3A4—Eplerenone—coronary artery disease	0.00964	0.0232	CbGbCtD
Pomalidomide—ABCB1—Atorvastatin—coronary artery disease	0.00924	0.0223	CbGbCtD
Pomalidomide—CYP3A4—Enalapril—coronary artery disease	0.00859	0.0207	CbGbCtD
Pomalidomide—ABCB1—Losartan—coronary artery disease	0.00845	0.0204	CbGbCtD
Pomalidomide—CYP3A4—Rosuvastatin—coronary artery disease	0.00668	0.0161	CbGbCtD
Pomalidomide—CYP3A4—Ezetimibe—coronary artery disease	0.00668	0.0161	CbGbCtD
Pomalidomide—CYP3A4—Simvastatin—coronary artery disease	0.00621	0.015	CbGbCtD
Pomalidomide—CYP3A4—Lovastatin—coronary artery disease	0.00608	0.0147	CbGbCtD
Pomalidomide—CYP3A4—Pravastatin—coronary artery disease	0.00608	0.0147	CbGbCtD
Pomalidomide—CYP3A4—Atorvastatin—coronary artery disease	0.00554	0.0134	CbGbCtD
Pomalidomide—CYP3A4—Losartan—coronary artery disease	0.00506	0.0122	CbGbCtD
Pomalidomide—Thalidomide—TNF—coronary artery disease	0.000731	0.33	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—coronary artery disease	0.000579	0.262	CrCbGaD
Pomalidomide—Thalidomide—CYP2C19—coronary artery disease	0.000558	0.252	CrCbGaD
Pomalidomide—TNF—blood—coronary artery disease	0.000502	0.155	CbGeAlD
Pomalidomide—CRBN—cardiac ventricle—coronary artery disease	0.00049	0.151	CbGeAlD
Pomalidomide—CRBN—myocardium—coronary artery disease	0.000461	0.142	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—coronary artery disease	0.000347	0.157	CrCbGaD
Pomalidomide—CRBN—heart—coronary artery disease	0.000322	0.0991	CbGeAlD
Pomalidomide—CRBN—cardiac atrium—coronary artery disease	0.000275	0.0847	CbGeAlD
Pomalidomide—CRBN—blood—coronary artery disease	0.00024	0.0739	CbGeAlD
Pomalidomide—PTGS2—artery—coronary artery disease	0.000238	0.0733	CbGeAlD
Pomalidomide—PTGS2—endothelium—coronary artery disease	0.000201	0.0619	CbGeAlD
Pomalidomide—PTGS2—heart—coronary artery disease	8.76e-05	0.027	CbGeAlD
Pomalidomide—PTGS2—cardiovascular system—coronary artery disease	8.27e-05	0.0255	CbGeAlD
Pomalidomide—Hypersensitivity—Valsartan—coronary artery disease	8.05e-05	0.000497	CcSEcCtD
Pomalidomide—Body temperature increased—Trandolapril—coronary artery disease	8.03e-05	0.000496	CcSEcCtD
Pomalidomide—Dizziness—Ezetimibe—coronary artery disease	8.02e-05	0.000495	CcSEcCtD
Pomalidomide—Body temperature increased—Enalapril—coronary artery disease	8e-05	0.000494	CcSEcCtD
Pomalidomide—Feeling abnormal—Captopril—coronary artery disease	8e-05	0.000494	CcSEcCtD
Pomalidomide—Insomnia—Losartan—coronary artery disease	7.99e-05	0.000493	CcSEcCtD
Pomalidomide—Rash—Fenofibrate—coronary artery disease	7.99e-05	0.000493	CcSEcCtD
Pomalidomide—Dermatitis—Fenofibrate—coronary artery disease	7.98e-05	0.000493	CcSEcCtD
Pomalidomide—Decreased appetite—Furosemide—coronary artery disease	7.96e-05	0.000491	CcSEcCtD
Pomalidomide—Headache—Fenofibrate—coronary artery disease	7.94e-05	0.00049	CcSEcCtD
Pomalidomide—Cough—Timolol—coronary artery disease	7.92e-05	0.000489	CcSEcCtD
Pomalidomide—Vomiting—Clopidogrel—coronary artery disease	7.92e-05	0.000489	CcSEcCtD
Pomalidomide—Diarrhoea—Simvastatin—coronary artery disease	7.92e-05	0.000489	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Furosemide—coronary artery disease	7.91e-05	0.000488	CcSEcCtD
Pomalidomide—Arthralgia—Ramipril—coronary artery disease	7.9e-05	0.000488	CcSEcCtD
Pomalidomide—Fatigue—Furosemide—coronary artery disease	7.9e-05	0.000487	CcSEcCtD
Pomalidomide—CYP1A2—blood—coronary artery disease	7.89e-05	0.0243	CbGeAlD
Pomalidomide—Tremor—Lisinopril—coronary artery disease	7.89e-05	0.000487	CcSEcCtD
Pomalidomide—Body temperature increased—Telmisartan—coronary artery disease	7.89e-05	0.000487	CcSEcCtD
Pomalidomide—Dyspnoea—Losartan—coronary artery disease	7.88e-05	0.000486	CcSEcCtD
Pomalidomide—Anxiety—Ramipril—coronary artery disease	7.88e-05	0.000486	CcSEcCtD
Pomalidomide—Vomiting—Lovastatin—coronary artery disease	7.86e-05	0.000486	CcSEcCtD
Pomalidomide—Dizziness—Eplerenone—coronary artery disease	7.85e-05	0.000485	CcSEcCtD
Pomalidomide—Rash—Clopidogrel—coronary artery disease	7.85e-05	0.000485	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.85e-05	0.000485	CcSEcCtD
Pomalidomide—Dermatitis—Clopidogrel—coronary artery disease	7.84e-05	0.000484	CcSEcCtD
Pomalidomide—Asthenia—Valsartan—coronary artery disease	7.84e-05	0.000484	CcSEcCtD
Pomalidomide—Pain—Furosemide—coronary artery disease	7.83e-05	0.000483	CcSEcCtD
Pomalidomide—Constipation—Furosemide—coronary artery disease	7.83e-05	0.000483	CcSEcCtD
Pomalidomide—Hypersensitivity—Niacin—coronary artery disease	7.83e-05	0.000483	CcSEcCtD
Pomalidomide—Asthenia—Olmesartan—coronary artery disease	7.8e-05	0.000482	CcSEcCtD
Pomalidomide—Headache—Clopidogrel—coronary artery disease	7.8e-05	0.000482	CcSEcCtD
Pomalidomide—Rash—Lovastatin—coronary artery disease	7.8e-05	0.000481	CcSEcCtD
Pomalidomide—Dermatitis—Lovastatin—coronary artery disease	7.79e-05	0.000481	CcSEcCtD
Pomalidomide—Anaemia—Lisinopril—coronary artery disease	7.78e-05	0.00048	CcSEcCtD
Pomalidomide—Feeling abnormal—Perindopril—coronary artery disease	7.76e-05	0.000479	CcSEcCtD
Pomalidomide—Headache—Lovastatin—coronary artery disease	7.75e-05	0.000478	CcSEcCtD
Pomalidomide—Pruritus—Valsartan—coronary artery disease	7.73e-05	0.000477	CcSEcCtD
Pomalidomide—Arthralgia—Timolol—coronary artery disease	7.73e-05	0.000477	CcSEcCtD
Pomalidomide—Vomiting—Ezetimibe—coronary artery disease	7.71e-05	0.000476	CcSEcCtD
Pomalidomide—Hypersensitivity—Pravastatin—coronary artery disease	7.71e-05	0.000476	CcSEcCtD
Pomalidomide—Anxiety—Timolol—coronary artery disease	7.7e-05	0.000475	CcSEcCtD
Pomalidomide—Pruritus—Olmesartan—coronary artery disease	7.69e-05	0.000475	CcSEcCtD
Pomalidomide—Decreased appetite—Losartan—coronary artery disease	7.68e-05	0.000474	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.67e-05	0.000474	CcSEcCtD
Pomalidomide—Body temperature increased—Captopril—coronary artery disease	7.67e-05	0.000474	CcSEcCtD
Pomalidomide—Dizziness—Simvastatin—coronary artery disease	7.65e-05	0.000472	CcSEcCtD
Pomalidomide—Rash—Ezetimibe—coronary artery disease	7.65e-05	0.000472	CcSEcCtD
Pomalidomide—Dermatitis—Ezetimibe—coronary artery disease	7.64e-05	0.000472	CcSEcCtD
Pomalidomide—Confusional state—Ramipril—coronary artery disease	7.64e-05	0.000472	CcSEcCtD
Pomalidomide—Asthenia—Niacin—coronary artery disease	7.62e-05	0.000471	CcSEcCtD
Pomalidomide—Fatigue—Losartan—coronary artery disease	7.62e-05	0.00047	CcSEcCtD
Pomalidomide—Headache—Ezetimibe—coronary artery disease	7.6e-05	0.000469	CcSEcCtD
Pomalidomide—Vertigo—Lisinopril—coronary artery disease	7.57e-05	0.000467	CcSEcCtD
Pomalidomide—Constipation—Losartan—coronary artery disease	7.56e-05	0.000466	CcSEcCtD
Pomalidomide—Pain—Losartan—coronary artery disease	7.56e-05	0.000466	CcSEcCtD
Pomalidomide—Vomiting—Eplerenone—coronary artery disease	7.55e-05	0.000466	CcSEcCtD
Pomalidomide—Feeling abnormal—Furosemide—coronary artery disease	7.55e-05	0.000466	CcSEcCtD
Pomalidomide—Leukopenia—Lisinopril—coronary artery disease	7.54e-05	0.000465	CcSEcCtD
Pomalidomide—Nausea—Fenofibrate—coronary artery disease	7.52e-05	0.000465	CcSEcCtD
Pomalidomide—Pruritus—Niacin—coronary artery disease	7.52e-05	0.000464	CcSEcCtD
Pomalidomide—Asthenia—Pravastatin—coronary artery disease	7.51e-05	0.000463	CcSEcCtD
Pomalidomide—Rash—Eplerenone—coronary artery disease	7.49e-05	0.000462	CcSEcCtD
Pomalidomide—Hypersensitivity—Trandolapril—coronary artery disease	7.48e-05	0.000462	CcSEcCtD
Pomalidomide—Dermatitis—Eplerenone—coronary artery disease	7.48e-05	0.000462	CcSEcCtD
Pomalidomide—Diarrhoea—Valsartan—coronary artery disease	7.48e-05	0.000461	CcSEcCtD
Pomalidomide—Confusional state—Timolol—coronary artery disease	7.47e-05	0.000461	CcSEcCtD
Pomalidomide—Hypersensitivity—Enalapril—coronary artery disease	7.45e-05	0.00046	CcSEcCtD
Pomalidomide—Body temperature increased—Perindopril—coronary artery disease	7.45e-05	0.00046	CcSEcCtD
Pomalidomide—Diarrhoea—Olmesartan—coronary artery disease	7.44e-05	0.000459	CcSEcCtD
Pomalidomide—Headache—Eplerenone—coronary artery disease	7.44e-05	0.000459	CcSEcCtD
Pomalidomide—Nervous system disorder—Ramipril—coronary artery disease	7.43e-05	0.000459	CcSEcCtD
Pomalidomide—Thrombocytopenia—Ramipril—coronary artery disease	7.42e-05	0.000458	CcSEcCtD
Pomalidomide—Pruritus—Pravastatin—coronary artery disease	7.4e-05	0.000457	CcSEcCtD
Pomalidomide—Nausea—Clopidogrel—coronary artery disease	7.4e-05	0.000457	CcSEcCtD
Pomalidomide—Skin disorder—Ramipril—coronary artery disease	7.36e-05	0.000454	CcSEcCtD
Pomalidomide—Infection—Timolol—coronary artery disease	7.36e-05	0.000454	CcSEcCtD
Pomalidomide—Vomiting—Simvastatin—coronary artery disease	7.36e-05	0.000454	CcSEcCtD
Pomalidomide—Hypersensitivity—Telmisartan—coronary artery disease	7.35e-05	0.000454	CcSEcCtD
Pomalidomide—Cough—Lisinopril—coronary artery disease	7.35e-05	0.000454	CcSEcCtD
Pomalidomide—Nausea—Lovastatin—coronary artery disease	7.35e-05	0.000454	CcSEcCtD
Pomalidomide—Hyperhidrosis—Ramipril—coronary artery disease	7.33e-05	0.000452	CcSEcCtD
Pomalidomide—Rash—Simvastatin—coronary artery disease	7.3e-05	0.00045	CcSEcCtD
Pomalidomide—Dermatitis—Simvastatin—coronary artery disease	7.29e-05	0.00045	CcSEcCtD
Pomalidomide—Asthenia—Trandolapril—coronary artery disease	7.29e-05	0.00045	CcSEcCtD
Pomalidomide—Feeling abnormal—Losartan—coronary artery disease	7.28e-05	0.00045	CcSEcCtD
Pomalidomide—Diarrhoea—Niacin—coronary artery disease	7.27e-05	0.000449	CcSEcCtD
Pomalidomide—Nervous system disorder—Timolol—coronary artery disease	7.26e-05	0.000448	CcSEcCtD
Pomalidomide—Asthenia—Enalapril—coronary artery disease	7.26e-05	0.000448	CcSEcCtD
Pomalidomide—Headache—Simvastatin—coronary artery disease	7.25e-05	0.000447	CcSEcCtD
Pomalidomide—Body temperature increased—Furosemide—coronary artery disease	7.24e-05	0.000447	CcSEcCtD
Pomalidomide—Dizziness—Valsartan—coronary artery disease	7.23e-05	0.000446	CcSEcCtD
Pomalidomide—Nausea—Ezetimibe—coronary artery disease	7.21e-05	0.000445	CcSEcCtD
Pomalidomide—Skin disorder—Timolol—coronary artery disease	7.2e-05	0.000444	CcSEcCtD
Pomalidomide—Dizziness—Olmesartan—coronary artery disease	7.19e-05	0.000444	CcSEcCtD
Pomalidomide—Pruritus—Trandolapril—coronary artery disease	7.19e-05	0.000444	CcSEcCtD
Pomalidomide—Arthralgia—Lisinopril—coronary artery disease	7.17e-05	0.000443	CcSEcCtD
Pomalidomide—Hyperhidrosis—Timolol—coronary artery disease	7.16e-05	0.000442	CcSEcCtD
Pomalidomide—Asthenia—Telmisartan—coronary artery disease	7.16e-05	0.000442	CcSEcCtD
Pomalidomide—Pruritus—Enalapril—coronary artery disease	7.16e-05	0.000442	CcSEcCtD
Pomalidomide—Diarrhoea—Pravastatin—coronary artery disease	7.16e-05	0.000442	CcSEcCtD
Pomalidomide—Anxiety—Lisinopril—coronary artery disease	7.14e-05	0.000441	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.12e-05	0.000439	CcSEcCtD
Pomalidomide—Pruritus—Telmisartan—coronary artery disease	7.06e-05	0.000436	CcSEcCtD
Pomalidomide—Nausea—Eplerenone—coronary artery disease	7.05e-05	0.000435	CcSEcCtD
Pomalidomide—Dizziness—Niacin—coronary artery disease	7.03e-05	0.000434	CcSEcCtD
Pomalidomide—Body temperature increased—Losartan—coronary artery disease	6.99e-05	0.000431	CcSEcCtD
Pomalidomide—Asthenia—Captopril—coronary artery disease	6.96e-05	0.00043	CcSEcCtD
Pomalidomide—Diarrhoea—Trandolapril—coronary artery disease	6.95e-05	0.000429	CcSEcCtD
Pomalidomide—Vomiting—Valsartan—coronary artery disease	6.95e-05	0.000429	CcSEcCtD
Pomalidomide—Confusional state—Lisinopril—coronary artery disease	6.93e-05	0.000428	CcSEcCtD
Pomalidomide—Diarrhoea—Enalapril—coronary artery disease	6.92e-05	0.000427	CcSEcCtD
Pomalidomide—Dizziness—Pravastatin—coronary artery disease	6.92e-05	0.000427	CcSEcCtD
Pomalidomide—Vomiting—Olmesartan—coronary artery disease	6.91e-05	0.000427	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.9e-05	0.000426	CcSEcCtD
Pomalidomide—Rash—Valsartan—coronary artery disease	6.89e-05	0.000425	CcSEcCtD
Pomalidomide—Dermatitis—Valsartan—coronary artery disease	6.88e-05	0.000425	CcSEcCtD
Pomalidomide—Nausea—Simvastatin—coronary artery disease	6.87e-05	0.000424	CcSEcCtD
Pomalidomide—Pruritus—Captopril—coronary artery disease	6.87e-05	0.000424	CcSEcCtD
Pomalidomide—Rash—Olmesartan—coronary artery disease	6.86e-05	0.000423	CcSEcCtD
Pomalidomide—Insomnia—Ramipril—coronary artery disease	6.85e-05	0.000423	CcSEcCtD
Pomalidomide—Dermatitis—Olmesartan—coronary artery disease	6.85e-05	0.000423	CcSEcCtD
Pomalidomide—Headache—Valsartan—coronary artery disease	6.85e-05	0.000423	CcSEcCtD
Pomalidomide—Diarrhoea—Telmisartan—coronary artery disease	6.83e-05	0.000421	CcSEcCtD
Pomalidomide—Infection—Lisinopril—coronary artery disease	6.83e-05	0.000421	CcSEcCtD
Pomalidomide—Headache—Olmesartan—coronary artery disease	6.81e-05	0.000421	CcSEcCtD
Pomalidomide—Asthenia—Perindopril—coronary artery disease	6.76e-05	0.000417	CcSEcCtD
Pomalidomide—Dyspnoea—Ramipril—coronary artery disease	6.76e-05	0.000417	CcSEcCtD
Pomalidomide—Vomiting—Niacin—coronary artery disease	6.75e-05	0.000417	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Timolol—coronary artery disease	6.75e-05	0.000417	CcSEcCtD
Pomalidomide—Hypersensitivity—Furosemide—coronary artery disease	6.75e-05	0.000417	CcSEcCtD
Pomalidomide—Thrombocytopenia—Lisinopril—coronary artery disease	6.73e-05	0.000415	CcSEcCtD
Pomalidomide—Dizziness—Trandolapril—coronary artery disease	6.72e-05	0.000415	CcSEcCtD
Pomalidomide—Insomnia—Timolol—coronary artery disease	6.7e-05	0.000414	CcSEcCtD
Pomalidomide—Rash—Niacin—coronary artery disease	6.7e-05	0.000414	CcSEcCtD
Pomalidomide—Dermatitis—Niacin—coronary artery disease	6.69e-05	0.000413	CcSEcCtD
Pomalidomide—Dizziness—Enalapril—coronary artery disease	6.69e-05	0.000413	CcSEcCtD
Pomalidomide—Skin disorder—Lisinopril—coronary artery disease	6.67e-05	0.000412	CcSEcCtD
Pomalidomide—Pruritus—Perindopril—coronary artery disease	6.67e-05	0.000411	CcSEcCtD
Pomalidomide—Headache—Niacin—coronary artery disease	6.66e-05	0.000411	CcSEcCtD
Pomalidomide—Vomiting—Pravastatin—coronary artery disease	6.65e-05	0.000411	CcSEcCtD
Pomalidomide—Hyperhidrosis—Lisinopril—coronary artery disease	6.64e-05	0.00041	CcSEcCtD
Pomalidomide—Diarrhoea—Captopril—coronary artery disease	6.64e-05	0.00041	CcSEcCtD
Pomalidomide—Dyspnoea—Timolol—coronary artery disease	6.6e-05	0.000408	CcSEcCtD
Pomalidomide—Dizziness—Telmisartan—coronary artery disease	6.6e-05	0.000407	CcSEcCtD
Pomalidomide—Rash—Pravastatin—coronary artery disease	6.6e-05	0.000407	CcSEcCtD
Pomalidomide—Dermatitis—Pravastatin—coronary artery disease	6.59e-05	0.000407	CcSEcCtD
Pomalidomide—Decreased appetite—Ramipril—coronary artery disease	6.59e-05	0.000407	CcSEcCtD
Pomalidomide—Asthenia—Furosemide—coronary artery disease	6.57e-05	0.000406	CcSEcCtD
Pomalidomide—Headache—Pravastatin—coronary artery disease	6.55e-05	0.000405	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Ramipril—coronary artery disease	6.54e-05	0.000404	CcSEcCtD
Pomalidomide—PTGS2—blood—coronary artery disease	6.54e-05	0.0201	CbGeAlD
Pomalidomide—Fatigue—Ramipril—coronary artery disease	6.53e-05	0.000403	CcSEcCtD
Pomalidomide—Hypersensitivity—Losartan—coronary artery disease	6.51e-05	0.000402	CcSEcCtD
Pomalidomide—Nausea—Valsartan—coronary artery disease	6.49e-05	0.000401	CcSEcCtD
Pomalidomide—Pruritus—Furosemide—coronary artery disease	6.48e-05	0.0004	CcSEcCtD
Pomalidomide—Constipation—Ramipril—coronary artery disease	6.48e-05	0.0004	CcSEcCtD
Pomalidomide—Nausea—Olmesartan—coronary artery disease	6.46e-05	0.000399	CcSEcCtD
Pomalidomide—Vomiting—Trandolapril—coronary artery disease	6.46e-05	0.000399	CcSEcCtD
Pomalidomide—Diarrhoea—Perindopril—coronary artery disease	6.45e-05	0.000398	CcSEcCtD
Pomalidomide—Decreased appetite—Timolol—coronary artery disease	6.44e-05	0.000398	CcSEcCtD
Pomalidomide—Vomiting—Enalapril—coronary artery disease	6.43e-05	0.000397	CcSEcCtD
Pomalidomide—Dizziness—Captopril—coronary artery disease	6.42e-05	0.000396	CcSEcCtD
Pomalidomide—Rash—Trandolapril—coronary artery disease	6.4e-05	0.000395	CcSEcCtD
Pomalidomide—Dermatitis—Trandolapril—coronary artery disease	6.4e-05	0.000395	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Timolol—coronary artery disease	6.4e-05	0.000395	CcSEcCtD
Pomalidomide—Fatigue—Timolol—coronary artery disease	6.39e-05	0.000394	CcSEcCtD
Pomalidomide—Rash—Enalapril—coronary artery disease	6.38e-05	0.000394	CcSEcCtD
Pomalidomide—Dermatitis—Enalapril—coronary artery disease	6.37e-05	0.000393	CcSEcCtD
Pomalidomide—Headache—Trandolapril—coronary artery disease	6.36e-05	0.000393	CcSEcCtD
Pomalidomide—Vomiting—Telmisartan—coronary artery disease	6.34e-05	0.000392	CcSEcCtD
Pomalidomide—Asthenia—Losartan—coronary artery disease	6.34e-05	0.000391	CcSEcCtD
Pomalidomide—Headache—Enalapril—coronary artery disease	6.34e-05	0.000391	CcSEcCtD
Pomalidomide—Pain—Timolol—coronary artery disease	6.33e-05	0.000391	CcSEcCtD
Pomalidomide—Nausea—Niacin—coronary artery disease	6.31e-05	0.00039	CcSEcCtD
Pomalidomide—Rash—Telmisartan—coronary artery disease	6.29e-05	0.000388	CcSEcCtD
Pomalidomide—Dermatitis—Telmisartan—coronary artery disease	6.29e-05	0.000388	CcSEcCtD
Pomalidomide—Diarrhoea—Furosemide—coronary artery disease	6.27e-05	0.000387	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.26e-05	0.000386	CcSEcCtD
Pomalidomide—Pruritus—Losartan—coronary artery disease	6.25e-05	0.000386	CcSEcCtD
Pomalidomide—Headache—Telmisartan—coronary artery disease	6.25e-05	0.000386	CcSEcCtD
Pomalidomide—Feeling abnormal—Ramipril—coronary artery disease	6.24e-05	0.000385	CcSEcCtD
Pomalidomide—Dizziness—Perindopril—coronary artery disease	6.23e-05	0.000385	CcSEcCtD
Pomalidomide—Insomnia—Lisinopril—coronary artery disease	6.22e-05	0.000384	CcSEcCtD
Pomalidomide—Nausea—Pravastatin—coronary artery disease	6.21e-05	0.000384	CcSEcCtD
Pomalidomide—Vomiting—Captopril—coronary artery disease	6.17e-05	0.000381	CcSEcCtD
Pomalidomide—Dyspnoea—Lisinopril—coronary artery disease	6.13e-05	0.000378	CcSEcCtD
Pomalidomide—Rash—Captopril—coronary artery disease	6.12e-05	0.000378	CcSEcCtD
Pomalidomide—Dermatitis—Captopril—coronary artery disease	6.11e-05	0.000377	CcSEcCtD
Pomalidomide—Feeling abnormal—Timolol—coronary artery disease	6.1e-05	0.000377	CcSEcCtD
Pomalidomide—Headache—Captopril—coronary artery disease	6.08e-05	0.000375	CcSEcCtD
Pomalidomide—Dizziness—Furosemide—coronary artery disease	6.06e-05	0.000374	CcSEcCtD
Pomalidomide—Diarrhoea—Losartan—coronary artery disease	6.05e-05	0.000373	CcSEcCtD
Pomalidomide—Nausea—Trandolapril—coronary artery disease	6.03e-05	0.000372	CcSEcCtD
Pomalidomide—Nausea—Enalapril—coronary artery disease	6.01e-05	0.000371	CcSEcCtD
Pomalidomide—Vomiting—Perindopril—coronary artery disease	5.99e-05	0.00037	CcSEcCtD
Pomalidomide—Body temperature increased—Ramipril—coronary artery disease	5.99e-05	0.00037	CcSEcCtD
Pomalidomide—Decreased appetite—Lisinopril—coronary artery disease	5.97e-05	0.000369	CcSEcCtD
Pomalidomide—Rash—Perindopril—coronary artery disease	5.94e-05	0.000367	CcSEcCtD
Pomalidomide—Dermatitis—Perindopril—coronary artery disease	5.93e-05	0.000366	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.93e-05	0.000366	CcSEcCtD
Pomalidomide—Nausea—Telmisartan—coronary artery disease	5.93e-05	0.000366	CcSEcCtD
Pomalidomide—Fatigue—Lisinopril—coronary artery disease	5.92e-05	0.000366	CcSEcCtD
Pomalidomide—Headache—Perindopril—coronary artery disease	5.9e-05	0.000364	CcSEcCtD
Pomalidomide—Constipation—Lisinopril—coronary artery disease	5.88e-05	0.000363	CcSEcCtD
Pomalidomide—Pain—Lisinopril—coronary artery disease	5.88e-05	0.000363	CcSEcCtD
Pomalidomide—Body temperature increased—Timolol—coronary artery disease	5.86e-05	0.000361	CcSEcCtD
Pomalidomide—Dizziness—Losartan—coronary artery disease	5.84e-05	0.000361	CcSEcCtD
Pomalidomide—Vomiting—Furosemide—coronary artery disease	5.82e-05	0.000359	CcSEcCtD
Pomalidomide—Rash—Furosemide—coronary artery disease	5.77e-05	0.000356	CcSEcCtD
Pomalidomide—Dermatitis—Furosemide—coronary artery disease	5.77e-05	0.000356	CcSEcCtD
Pomalidomide—Nausea—Captopril—coronary artery disease	5.76e-05	0.000356	CcSEcCtD
Pomalidomide—Headache—Furosemide—coronary artery disease	5.74e-05	0.000354	CcSEcCtD
Pomalidomide—CYP3A4—blood—coronary artery disease	5.71e-05	0.0176	CbGeAlD
Pomalidomide—Feeling abnormal—Lisinopril—coronary artery disease	5.66e-05	0.00035	CcSEcCtD
Pomalidomide—Vomiting—Losartan—coronary artery disease	5.62e-05	0.000347	CcSEcCtD
Pomalidomide—Nausea—Perindopril—coronary artery disease	5.6e-05	0.000345	CcSEcCtD
Pomalidomide—Hypersensitivity—Ramipril—coronary artery disease	5.58e-05	0.000345	CcSEcCtD
Pomalidomide—Rash—Losartan—coronary artery disease	5.57e-05	0.000344	CcSEcCtD
Pomalidomide—Dermatitis—Losartan—coronary artery disease	5.57e-05	0.000344	CcSEcCtD
Pomalidomide—Headache—Losartan—coronary artery disease	5.54e-05	0.000342	CcSEcCtD
Pomalidomide—Hypersensitivity—Timolol—coronary artery disease	5.46e-05	0.000337	CcSEcCtD
Pomalidomide—Nausea—Furosemide—coronary artery disease	5.44e-05	0.000336	CcSEcCtD
Pomalidomide—Asthenia—Ramipril—coronary artery disease	5.44e-05	0.000336	CcSEcCtD
Pomalidomide—Body temperature increased—Lisinopril—coronary artery disease	5.43e-05	0.000335	CcSEcCtD
Pomalidomide—ABCB1—heart—coronary artery disease	5.42e-05	0.0167	CbGeAlD
Pomalidomide—Pruritus—Ramipril—coronary artery disease	5.36e-05	0.000331	CcSEcCtD
Pomalidomide—Asthenia—Timolol—coronary artery disease	5.31e-05	0.000328	CcSEcCtD
Pomalidomide—Nausea—Losartan—coronary artery disease	5.25e-05	0.000324	CcSEcCtD
Pomalidomide—Pruritus—Timolol—coronary artery disease	5.24e-05	0.000324	CcSEcCtD
Pomalidomide—Diarrhoea—Ramipril—coronary artery disease	5.18e-05	0.00032	CcSEcCtD
Pomalidomide—ABCB1—cardiovascular system—coronary artery disease	5.11e-05	0.0157	CbGeAlD
Pomalidomide—Diarrhoea—Timolol—coronary artery disease	5.07e-05	0.000313	CcSEcCtD
Pomalidomide—Hypersensitivity—Lisinopril—coronary artery disease	5.06e-05	0.000313	CcSEcCtD
Pomalidomide—Dizziness—Ramipril—coronary artery disease	5.01e-05	0.000309	CcSEcCtD
Pomalidomide—Asthenia—Lisinopril—coronary artery disease	4.93e-05	0.000304	CcSEcCtD
Pomalidomide—Dizziness—Timolol—coronary artery disease	4.9e-05	0.000302	CcSEcCtD
Pomalidomide—Pruritus—Lisinopril—coronary artery disease	4.86e-05	0.0003	CcSEcCtD
Pomalidomide—Vomiting—Ramipril—coronary artery disease	4.82e-05	0.000297	CcSEcCtD
Pomalidomide—Rash—Ramipril—coronary artery disease	4.78e-05	0.000295	CcSEcCtD
Pomalidomide—Dermatitis—Ramipril—coronary artery disease	4.77e-05	0.000295	CcSEcCtD
Pomalidomide—Headache—Ramipril—coronary artery disease	4.75e-05	0.000293	CcSEcCtD
Pomalidomide—Vomiting—Timolol—coronary artery disease	4.71e-05	0.000291	CcSEcCtD
Pomalidomide—Diarrhoea—Lisinopril—coronary artery disease	4.7e-05	0.00029	CcSEcCtD
Pomalidomide—Rash—Timolol—coronary artery disease	4.67e-05	0.000288	CcSEcCtD
Pomalidomide—Dermatitis—Timolol—coronary artery disease	4.67e-05	0.000288	CcSEcCtD
Pomalidomide—Headache—Timolol—coronary artery disease	4.64e-05	0.000286	CcSEcCtD
Pomalidomide—Dizziness—Lisinopril—coronary artery disease	4.54e-05	0.000281	CcSEcCtD
Pomalidomide—Nausea—Ramipril—coronary artery disease	4.5e-05	0.000278	CcSEcCtD
Pomalidomide—Nausea—Timolol—coronary artery disease	4.4e-05	0.000272	CcSEcCtD
Pomalidomide—Vomiting—Lisinopril—coronary artery disease	4.37e-05	0.00027	CcSEcCtD
Pomalidomide—Rash—Lisinopril—coronary artery disease	4.33e-05	0.000267	CcSEcCtD
Pomalidomide—Dermatitis—Lisinopril—coronary artery disease	4.33e-05	0.000267	CcSEcCtD
Pomalidomide—Headache—Lisinopril—coronary artery disease	4.31e-05	0.000266	CcSEcCtD
Pomalidomide—Nausea—Lisinopril—coronary artery disease	4.08e-05	0.000252	CcSEcCtD
Pomalidomide—ABCB1—blood—coronary artery disease	4.04e-05	0.0125	CbGeAlD
Pomalidomide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.6e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DLAT—coronary artery disease	5.6e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COX5B—coronary artery disease	5.6e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.6e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.6e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC22A3—coronary artery disease	5.58e-06	5.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT5A—coronary artery disease	5.51e-06	5.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ARNTL—coronary artery disease	5.5e-06	5.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HADH—coronary artery disease	5.5e-06	5.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCA1—coronary artery disease	5.43e-06	5.46e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—VCAN—coronary artery disease	5.42e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—coronary artery disease	5.42e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.41e-06	5.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDOA—coronary artery disease	5.38e-06	5.41e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.34e-06	5.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOB—coronary artery disease	5.33e-06	5.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.31e-06	5.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.28e-06	5.31e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GGT1—coronary artery disease	5.26e-06	5.29e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT1—coronary artery disease	5.26e-06	5.29e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DCN—coronary artery disease	5.22e-06	5.25e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX2—coronary artery disease	5.21e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	5.21e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA2—coronary artery disease	5.21e-06	5.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX4—coronary artery disease	5.15e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG5—coronary artery disease	5.15e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HK1—coronary artery disease	5.15e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SULT1A1—coronary artery disease	5.15e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	5.14e-06	5.17e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF1—coronary artery disease	5.12e-06	5.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HADHA—coronary artery disease	5.09e-06	5.12e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—coronary artery disease	5.09e-06	5.12e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH2—coronary artery disease	5.08e-06	5.11e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.06e-06	5.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HK2—coronary artery disease	5.06e-06	5.09e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA1—coronary artery disease	5.03e-06	5.06e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—coronary artery disease	5e-06	5.03e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPA—coronary artery disease	4.97e-06	5e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LIPC—coronary artery disease	4.95e-06	4.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBA1—coronary artery disease	4.95e-06	4.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2C19—coronary artery disease	4.95e-06	4.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3C2A—coronary artery disease	4.95e-06	4.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOC3—coronary artery disease	4.92e-06	4.95e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LDLR—coronary artery disease	4.89e-06	4.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.85e-06	4.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—coronary artery disease	4.83e-06	4.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC9A1—coronary artery disease	4.83e-06	4.86e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLCB3—coronary artery disease	4.82e-06	4.84e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCLC—coronary artery disease	4.77e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CETP—coronary artery disease	4.77e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPP2CA—coronary artery disease	4.77e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA5—coronary artery disease	4.77e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.76e-06	4.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LCAT—coronary artery disease	4.76e-06	4.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—coronary artery disease	4.72e-06	4.75e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SDC1—coronary artery disease	4.72e-06	4.75e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	4.69e-06	4.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRKCD—coronary artery disease	4.69e-06	4.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARGC1A—coronary artery disease	4.68e-06	4.71e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—P4HB—coronary artery disease	4.67e-06	4.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA4—coronary artery disease	4.67e-06	4.7e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—coronary artery disease	4.66e-06	4.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.63e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—coronary artery disease	4.59e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	4.59e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—coronary artery disease	4.58e-06	4.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.54e-06	4.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCLM—coronary artery disease	4.51e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.51e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.48e-06	4.51e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOB—coronary artery disease	4.46e-06	4.49e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PSMB5—coronary artery disease	4.46e-06	4.49e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PSMA6—coronary artery disease	4.46e-06	4.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.37e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.37e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—coronary artery disease	4.37e-06	4.39e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CTGF—coronary artery disease	4.36e-06	4.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—coronary artery disease	4.34e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—VCAN—coronary artery disease	4.33e-06	4.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMGCR—coronary artery disease	4.32e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT2—coronary artery disease	4.32e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.3e-06	4.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.29e-06	4.32e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—coronary artery disease	4.26e-06	4.29e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—coronary artery disease	4.26e-06	4.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.24e-06	4.27e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HADH—coronary artery disease	4.24e-06	4.27e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.23e-06	4.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—coronary artery disease	4.21e-06	4.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DCN—coronary artery disease	4.17e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—coronary artery disease	4.16e-06	4.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.05e-06	4.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD36—coronary artery disease	4.05e-06	4.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.02e-06	4.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX2—coronary artery disease	4.02e-06	4.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA2—coronary artery disease	4.02e-06	4.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6ST—coronary artery disease	4e-06	4.03e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPP2CA—coronary artery disease	4e-06	4.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX4—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HK1—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLCB1—coronary artery disease	3.97e-06	3.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.95e-06	3.98e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LIPC—coronary artery disease	3.95e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBA1—coronary artery disease	3.95e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2C19—coronary artery disease	3.95e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	3.95e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HADHA—coronary artery disease	3.93e-06	3.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOC3—coronary artery disease	3.93e-06	3.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LDLR—coronary artery disease	3.9e-06	3.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.9e-06	3.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.88e-06	3.9e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.85e-06	3.88e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.85e-06	3.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCA1—coronary artery disease	3.85e-06	3.87e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KIT—coronary artery disease	3.85e-06	3.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPA—coronary artery disease	3.84e-06	3.86e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—coronary artery disease	3.83e-06	3.86e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCLC—coronary artery disease	3.81e-06	3.83e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CETP—coronary artery disease	3.81e-06	3.83e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SDC1—coronary artery disease	3.77e-06	3.79e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT1—coronary artery disease	3.73e-06	3.75e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT1—coronary artery disease	3.73e-06	3.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.72e-06	3.74e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3B—coronary artery disease	3.69e-06	3.71e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA5—coronary artery disease	3.68e-06	3.7e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CREB1—coronary artery disease	3.66e-06	3.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—coronary artery disease	3.64e-06	3.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—P4HB—coronary artery disease	3.61e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6R—coronary artery disease	3.57e-06	3.59e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—coronary artery disease	3.57e-06	3.59e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.56e-06	3.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.56e-06	3.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.55e-06	3.57e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.54e-06	3.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—coronary artery disease	3.53e-06	3.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CTGF—coronary artery disease	3.48e-06	3.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.45e-06	3.47e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT2—coronary artery disease	3.45e-06	3.47e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.38e-06	3.4e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—coronary artery disease	3.35e-06	3.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—coronary artery disease	3.35e-06	3.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—VCAN—coronary artery disease	3.34e-06	3.36e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.32e-06	3.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.31e-06	3.33e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—coronary artery disease	3.3e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—coronary artery disease	3.26e-06	3.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF2—coronary artery disease	3.24e-06	3.26e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DCN—coronary artery disease	3.22e-06	3.23e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—coronary artery disease	3.19e-06	3.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.17e-06	3.19e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOB—coronary artery disease	3.16e-06	3.18e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.13e-06	3.15e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—coronary artery disease	3.11e-06	3.13e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.11e-06	3.13e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JAK2—coronary artery disease	3.1e-06	3.12e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—coronary artery disease	3.08e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.07e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—coronary artery disease	3.07e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.05e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.05e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LIPC—coronary artery disease	3.05e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBA1—coronary artery disease	3.05e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOC3—coronary artery disease	3.03e-06	3.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—coronary artery disease	3.02e-06	3.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LDLR—coronary artery disease	3.01e-06	3.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.98e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.98e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT1—coronary artery disease	2.97e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT1—coronary artery disease	2.97e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—coronary artery disease	2.95e-06	2.96e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CETP—coronary artery disease	2.94e-06	2.96e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCLC—coronary artery disease	2.94e-06	2.96e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SDC1—coronary artery disease	2.91e-06	2.93e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD36—coronary artery disease	2.87e-06	2.89e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.83e-06	2.85e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—coronary artery disease	2.8e-06	2.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.75e-06	2.76e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.75e-06	2.76e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—coronary artery disease	2.72e-06	2.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CTGF—coronary artery disease	2.68e-06	2.7e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—coronary artery disease	2.67e-06	2.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.67e-06	2.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.66e-06	2.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT2—coronary artery disease	2.66e-06	2.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.65e-06	2.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.64e-06	2.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—coronary artery disease	2.6e-06	2.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—coronary artery disease	2.58e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—coronary artery disease	2.53e-06	2.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOB—coronary artery disease	2.52e-06	2.54e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—coronary artery disease	2.5e-06	2.52e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.46e-06	2.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.45e-06	2.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—coronary artery disease	2.41e-06	2.42e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.37e-06	2.38e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—coronary artery disease	2.35e-06	2.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT1—coronary artery disease	2.3e-06	2.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT1—coronary artery disease	2.3e-06	2.31e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD36—coronary artery disease	2.29e-06	2.3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.26e-06	2.27e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—coronary artery disease	2.2e-06	2.22e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—coronary artery disease	2.17e-06	2.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.17e-06	2.18e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—coronary artery disease	2.11e-06	2.12e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAPK1—coronary artery disease	2.07e-06	2.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.06e-06	2.07e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—coronary artery disease	2.06e-06	2.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.04e-06	2.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.03e-06	2.05e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—coronary artery disease	2.02e-06	2.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—coronary artery disease	2.01e-06	2.02e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—coronary artery disease	2e-06	2.01e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—coronary artery disease	1.98e-06	1.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOB—coronary artery disease	1.95e-06	1.96e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.91e-06	1.92e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—coronary artery disease	1.9e-06	1.91e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.9e-06	1.91e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—coronary artery disease	1.86e-06	1.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—coronary artery disease	1.81e-06	1.83e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CA—coronary artery disease	1.8e-06	1.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD36—coronary artery disease	1.77e-06	1.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—coronary artery disease	1.76e-06	1.77e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.75e-06	1.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—coronary artery disease	1.74e-06	1.75e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—coronary artery disease	1.73e-06	1.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.67e-06	1.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—coronary artery disease	1.59e-06	1.6e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—coronary artery disease	1.59e-06	1.6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—coronary artery disease	1.58e-06	1.59e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—coronary artery disease	1.56e-06	1.57e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—coronary artery disease	1.54e-06	1.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—coronary artery disease	1.51e-06	1.52e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CA—coronary artery disease	1.51e-06	1.51e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—coronary artery disease	1.47e-06	1.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.38e-06	1.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—coronary artery disease	1.36e-06	1.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—coronary artery disease	1.34e-06	1.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—coronary artery disease	1.23e-06	1.24e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—coronary artery disease	1.22e-06	1.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—coronary artery disease	1.17e-06	1.18e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.07e-06	1.07e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.07e-06	1.07e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—coronary artery disease	8.72e-07	8.77e-06	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.52e-07	8.57e-06	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—coronary artery disease	6.96e-07	7e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.57e-07	6.61e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—coronary artery disease	5.37e-07	5.4e-06	CbGpPWpGaD
